Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management
Jay W Mason,1 Thomas E Moon2 1School of Medicine, University of Utah, Salt Lake City, UT, 2Tarizona eHealth Services, Inc, Emeryville, CA, USA Abstract: 5-HT3 antagonists have been available as oral and intravenous preparations for decades. The availability more recently of transdermal granisetron a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/use-and-cardiovascular-safety-of-transdermal-and-other-granisetron-pre-a13822 |